Aeglea BioTherapeutics is a clinical stage company developing enzyme therapies for rare metabolic diseases like Arginase 1 Deficiency and Homocystinuria.

Aeglea BioTherapeutics | Rare Metabolic Disease | Home


Redirect me
Take me to your homepage

You are about to be redirected to another page. We are not responsible for the content of that page or the consequences it may have on you.